NEW YORK (Reuters Health) – Patients with esophageal cancer appear to have equally good survival after minimally invasive esophagectomy (MIE) or traditional open surgery, according to a new…
NEW YORK (Reuters Health) – In women with hormone-receptor-positive metastatic breast cancer, combining anastrozole and fulvestrant extends progression-free and overall survival, according to a paper released online today…
NEW YORK (Reuters Health) – Adding gemtuzumab ozogamicin (GO) to induction chemotherapy improved survival in older patients with acute myeloid leukemia (AML), with no apparent additional toxicity, in…
Stacy Loeb, MD discusses how the decision for prostate cancer screening should be an individual one, rather than population-based. Individual risk factors including age, general health, family history,…
It’s highly debated whether patients undergoing radiation therapy for prostate cancer should also have their lymph nodes treated. Janna Andrews, MD, discusses the RTOG trials and their results, which…
Charles Jungreis, MD, Chairperson, Department of Radiology, Professor, Temple University School of Medicine, discusses stereotactic radiosurgery. References and Resources Cesaretti JA, Pennathur A, Rosenstein BS, Swanson SJ, Fernando…
Dr. Francis Cordova, Medical Director of the Lung Transplantation Program at Temple University School of Medicine, discusses the factors that determine strong and weak candidates for lung transplantation…
NEW YORK (Reuters Health) – The increased risk of breast cancer in women who received radiotherapy above the diaphragm for treatment of Hodgkin’s lymphoma (HL) persists for at…
The recent PLCO study and its results have sparked controversy in some circles. The trial concludes that routine PSA exams and digital rectal exams, standard screening exams for prostate cancer,…
NEW YORK (Reuters Health) – For patients undergoing a transrectal prostate biopsy, a pelvic plexus block (PPB) is more effective than a periprostatic nerve block for controlling pain,…
